Aucta Pharmaceuticals, Inc. (AUCTA, Latin-improved, enhanced) is a technology based product company focusing on creating better products of anch ored in a proven molecule. Using 505(b)(2) regulatory pathway, through innovation, Aucta is creating new therapeutics, including new dosage form, new dosing regimen and new indications. With operations in New Jersey, U.S. and Shanghai, China. the firm has a therapeutic focus in CNS , Dermatology and Pediatric is patient centric by continuously bringing improved form of proven molecule into the market place.
